PFK Obnovlenie

Renewal (PFK Obnovlenie) is one of the largest independent pharmaceutical manufacturers in Russia, specializing in the production of high-quality generic medications. Headquartered in Novosibirsk, the company operates advanced manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards. Its extensive product portfolio encompasses over 200 medications across diverse therapeutic areas, including cardiology, neurology, gastroenterology, and endocrinology. The company provides a wide range of dosage forms, such as tablets, capsules, injectable solutions, and ophthalmic drops, serving both retail pharmacies and hospital segments. Renewal plays a pivotal role in the Russian healthcare landscape by ensuring the availability of affordable, domestically produced essential medicines. Through continuous investment in production capacity and research, the company remains a leader in the Russian pharmaceutical industry's import substitution efforts.